AXITINIB Sandoz cpr pell 5 mg 56 pce
7680694720052
CH-69472
L01EK01
07.16.1.
Reimbursement limitations:
INLYTA
Traitement de patients atteints d’un carcinome rénal avancé (RCC) après échec d’un traitement systémique préalable.
1 / 3
google
Details
- Product number
- 6947203
- CPT
- -
- Packaging group
- 56
- Unit
- Tablette(n)
- Composition
- axitinibum 5 mg, lactosum monohydricum, cellulosum microcristallinum, carmellosum natricum conexum corresp. natrium 0.46 mg, magnesii stearas, Überzug: hypromellosum, lactosum monohydricum, E 171, E 172 (rubrum), triacetinum, pro compresso obducto corresp. lactosum monohydricum 165.60 mg.
Articles (1)
Axitinib Sandoz 5 mg, Filmtabletten
Filmtabletten
56
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
5.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
0.46 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HBESI |
|
(N/A)
|
- | Substance | FNIDK |
|
(N/A)
|
- | Substance | FTODK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
165.6 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 2017.55
Specialties list
Yes
Generic
Yes
Reimbursement limitation
SL addition date:
01/07/2025
Authorization holder
Sandoz Pharmaceuticals AG
6343 Risch
Authorization information
- Swissmedic authorization number
- 69472
- Drug name
- Axitinib Sandoz, Filmtabletten
- Galenic form
- FILM
- ATC Code
- L01EK01
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 22/02/2024
- Authorization expiration date
- 21/02/2029
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- AXITINIB Sandoz cpr pell 5 mg 56 pce
- Description (DE)
- AXITINIB Sandoz Filmtabl 5 mg 56 Stk
- Market launch
- 30/06/2025
- Narcotic (BTM)
- No